Markets
About
QuiO Care Platform - the combination of our mobile health app wirelessly communicating with our subcutaneous delivery system for self-administration of biologics (monoclonal antibodies, fusion proteins, etc.) The Platform enables all biologics, even those currently restricted to the clinic, to be self-administered by patients in their home. This is achieved by a proprietary injection technology capable of detecting the quality of the drug solution at the point-of-care. Communication between the injection device and mobile health application also enables remote monitoring of patient adherence to the prescribed treatment regimen.